Situation – Unzufriedenheit!
Ursache – Volk hat keine Macht!
Lösung – Volksentscheid!
WAS IST DIE GRUNDLAGE FÜR VERÄNDERUNGEN?
Der VOLKSENTSCHEID ALS HÖCHSTE DEMOKRATISCHE ENTSCHEIDUNG NACH SCHWEIZER VORBILD IN DIE LANDESVERFASSUNG!
Politik wird genau dann für das Volk gemacht, wenn das Volk die höchste Gewalt im Land hat und jede Entscheidung der Politiker abändern kann!
Unsere 4 Ziele bis zur Landtagswahl!
1
Aufklären - über reale Situation in Deutschland! (Zahlen/Fakten)
Unzufriedenheit hat Ursachen und diese müssen wir kennen, um das Konzept der Demokraten zu verstehen. Dazu werden wir zu allen relevanten Themen die wichtigsten Zahlen, Daten und Fakten zusammenfassen und zur Verfügung stellen.
2
Transparenzverpflichtung in die Landesverfassung!
Die verpflichtende Aufnahme der Veröffentlichung aller Steuern, Abgaben, Verträgen und Kosten des Öffentlichen Dienstes auf allen Ebenen!
3
Why do I need a COVID-19 antibody test?
- Knowing your vaccination is effective can provide peace of mind. With the recent FDA approval of vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19), testing that quantitatively measures the production of these specific antibodies toward COVID-19 has become clinically valuable in the evaluation of vaccine response. The recently approved mRNA vaccines induce antibody response against the SARS-CoV-2 spike protein. Spike protein antibodies demonstrate potent antiviral activity and correlate with potential immunity. Antibodies against the virus after a natural COVID-19 infection are present; however, these significantly decrease over time. The duration of antibody protection varies from person-to-person. Likewise, antibody levels can determine protection from COVID-19 infection post-vaccination. The presence of antibodies in both cases may indicate protection against severe course of infection or reinfection.
What makes KSL's antibody testing special?
-
KSL offers a NYSDOH-approved test for measurement of antibodies to spike and nucleocapsid proteins. Recognizing the need for tests to determine immune response post-infection or post-vaccination, KSL has designed and developed its highly accurate, isotype-specific IgG, IgM and IgA chemiluminescence immunoassays against the COVID-19 spike and nucleocapsid proteins—effectively detecting and differentiating between post-infection and vaccine-mediated antibody response (including Pfizer and Moderna vaccines).
-
Many COVID-19 antibody tests are not valid for testing vaccine effectiveness due to targeting the wrong proteins or suffering from poor sensitivity and specificity. KSL’s COVID-19 antibody test provides a peace of mind, detecting an immune response in both vaccinated and previously COVID-19 infected individuals.
What are COVID-19 antibodies?
-
Antibodies are one way an individual’s immune system fights infections. People with a healthy immune system develop antibodies against COVID-19 virus shortly after infection. These antibodies are detectable by laboratory tests after about one week after initial infection. In most people, the antibodies clear the COVID-19 infection after about two weeks. While the antibodies are detectable later than the virus, they may help establish the initial diagnosis of a symptomatic patient and offer additional benefits such as indicating an individual’s resistance to the virus and reinfection — if the virus is no longer detectable, these people present a minimal risk of spreading the virus.
What can my COVID-19 test results tell me?
- Consult this table for basic interpretation of results. This is a guide. Please consult your healthcare provider assistance with your diagnosis and more detailed information.
How much does the test cost and who pays for it?
-
COVID-19 Antibody Testing is for isotype-specific IgG, IgM and IgA COVID-19 spike protein (chemiluminescence, $150) and nucleocapsid total antibody (ELISA, $50), or both tests ($200). Testing may be covered by private insurance, Medicaid, Medicare and other governmental reimbursers. If you have specific questions, please call KSL at 1-800-960-1080 to speak with a representative.
Does insurance cover this test?
- Insurance will generally cover testing for patients with a prescription from a doctor.
Are these tests approved by FDA?
- The COVID-19 tests currently offered by KSL are approved by FDA through Emergency Use Authorization (EUA).
4
Why do I need a COVID-19 antibody test?
- Knowing your vaccination is effective can provide peace of mind. With the recent FDA approval of vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19), testing that quantitatively measures the production of these specific antibodies toward COVID-19 has become clinically valuable in the evaluation of vaccine response. The recently approved mRNA vaccines induce antibody response against the SARS-CoV-2 spike protein. Spike protein antibodies demonstrate potent antiviral activity and correlate with potential immunity. Antibodies against the virus after a natural COVID-19 infection are present; however, these significantly decrease over time. The duration of antibody protection varies from person-to-person. Likewise, antibody levels can determine protection from COVID-19 infection post-vaccination. The presence of antibodies in both cases may indicate protection against severe course of infection or reinfection.
What makes KSL's antibody testing special?
-
KSL offers a NYSDOH-approved test for measurement of antibodies to spike and nucleocapsid proteins. Recognizing the need for tests to determine immune response post-infection or post-vaccination, KSL has designed and developed its highly accurate, isotype-specific IgG, IgM and IgA chemiluminescence immunoassays against the COVID-19 spike and nucleocapsid proteins—effectively detecting and differentiating between post-infection and vaccine-mediated antibody response (including Pfizer and Moderna vaccines).
-
Many COVID-19 antibody tests are not valid for testing vaccine effectiveness due to targeting the wrong proteins or suffering from poor sensitivity and specificity. KSL’s COVID-19 antibody test provides a peace of mind, detecting an immune response in both vaccinated and previously COVID-19 infected individuals.
What are COVID-19 antibodies?
-
Antibodies are one way an individual’s immune system fights infections. People with a healthy immune system develop antibodies against COVID-19 virus shortly after infection. These antibodies are detectable by laboratory tests after about one week after initial infection. In most people, the antibodies clear the COVID-19 infection after about two weeks. While the antibodies are detectable later than the virus, they may help establish the initial diagnosis of a symptomatic patient and offer additional benefits such as indicating an individual’s resistance to the virus and reinfection — if the virus is no longer detectable, these people present a minimal risk of spreading the virus.
What can my COVID-19 test results tell me?
- Consult this table for basic interpretation of results. This is a guide. Please consult your healthcare provider assistance with your diagnosis and more detailed information.
How much does the test cost and who pays for it?
-
COVID-19 Antibody Testing is for isotype-specific IgG, IgM and IgA COVID-19 spike protein (chemiluminescence, $150) and nucleocapsid total antibody (ELISA, $50), or both tests ($200). Testing may be covered by private insurance, Medicaid, Medicare and other governmental reimbursers. If you have specific questions, please call KSL at 1-800-960-1080 to speak with a representative.
Does insurance cover this test?
- Insurance will generally cover testing for patients with a prescription from a doctor.
Are these tests approved by FDA?
- The COVID-19 tests currently offered by KSL are approved by FDA through Emergency Use Authorization (EUA).
Unsere 4 Ziele nach der Landtagswahl!
1
Aufklären - über reale Situation in Deutschland! (Zahlen/Fakten)
Unzufriedenheit hat Ursachen und diese müssen wir kennen, um das Konzept der Demokraten zu verstehen. Dazu werden wir zu allen relevanten Themen die wichtigsten Zahlen, Daten und Fakten zusammenfassen und zur Verfügung stellen.
2
Why do I need a COVID-19 antibody test?
- Knowing your vaccination is effective can provide peace of mind. With the recent FDA approval of vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19), testing that quantitatively measures the production of these specific antibodies toward COVID-19 has become clinically valuable in the evaluation of vaccine response. The recently approved mRNA vaccines induce antibody response against the SARS-CoV-2 spike protein. Spike protein antibodies demonstrate potent antiviral activity and correlate with potential immunity. Antibodies against the virus after a natural COVID-19 infection are present; however, these significantly decrease over time. The duration of antibody protection varies from person-to-person. Likewise, antibody levels can determine protection from COVID-19 infection post-vaccination. The presence of antibodies in both cases may indicate protection against severe course of infection or reinfection.
What makes KSL's antibody testing special?
-
KSL offers a NYSDOH-approved test for measurement of antibodies to spike and nucleocapsid proteins. Recognizing the need for tests to determine immune response post-infection or post-vaccination, KSL has designed and developed its highly accurate, isotype-specific IgG, IgM and IgA chemiluminescence immunoassays against the COVID-19 spike and nucleocapsid proteins—effectively detecting and differentiating between post-infection and vaccine-mediated antibody response (including Pfizer and Moderna vaccines).
-
Many COVID-19 antibody tests are not valid for testing vaccine effectiveness due to targeting the wrong proteins or suffering from poor sensitivity and specificity. KSL’s COVID-19 antibody test provides a peace of mind, detecting an immune response in both vaccinated and previously COVID-19 infected individuals.
What are COVID-19 antibodies?
-
Antibodies are one way an individual’s immune system fights infections. People with a healthy immune system develop antibodies against COVID-19 virus shortly after infection. These antibodies are detectable by laboratory tests after about one week after initial infection. In most people, the antibodies clear the COVID-19 infection after about two weeks. While the antibodies are detectable later than the virus, they may help establish the initial diagnosis of a symptomatic patient and offer additional benefits such as indicating an individual’s resistance to the virus and reinfection — if the virus is no longer detectable, these people present a minimal risk of spreading the virus.
What can my COVID-19 test results tell me?
- Consult this table for basic interpretation of results. This is a guide. Please consult your healthcare provider assistance with your diagnosis and more detailed information.
How much does the test cost and who pays for it?
-
COVID-19 Antibody Testing is for isotype-specific IgG, IgM and IgA COVID-19 spike protein (chemiluminescence, $150) and nucleocapsid total antibody (ELISA, $50), or both tests ($200). Testing may be covered by private insurance, Medicaid, Medicare and other governmental reimbursers. If you have specific questions, please call KSL at 1-800-960-1080 to speak with a representative.
Does insurance cover this test?
- Insurance will generally cover testing for patients with a prescription from a doctor.
Are these tests approved by FDA?
- The COVID-19 tests currently offered by KSL are approved by FDA through Emergency Use Authorization (EUA).
3
Transparenzverpflichtung in die Landesverfassung!
Die verpflichtende Aufnahme der Veröffentlichung aller Steuern, Abgaben, Verträgen und Kosten des Öffentlichen Dienstes auf allen Ebenen!
4
Why do I need a COVID-19 antibody test?
- Knowing your vaccination is effective can provide peace of mind. With the recent FDA approval of vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19), testing that quantitatively measures the production of these specific antibodies toward COVID-19 has become clinically valuable in the evaluation of vaccine response. The recently approved mRNA vaccines induce antibody response against the SARS-CoV-2 spike protein. Spike protein antibodies demonstrate potent antiviral activity and correlate with potential immunity. Antibodies against the virus after a natural COVID-19 infection are present; however, these significantly decrease over time. The duration of antibody protection varies from person-to-person. Likewise, antibody levels can determine protection from COVID-19 infection post-vaccination. The presence of antibodies in both cases may indicate protection against severe course of infection or reinfection.
What makes KSL's antibody testing special?
-
KSL offers a NYSDOH-approved test for measurement of antibodies to spike and nucleocapsid proteins. Recognizing the need for tests to determine immune response post-infection or post-vaccination, KSL has designed and developed its highly accurate, isotype-specific IgG, IgM and IgA chemiluminescence immunoassays against the COVID-19 spike and nucleocapsid proteins—effectively detecting and differentiating between post-infection and vaccine-mediated antibody response (including Pfizer and Moderna vaccines).
-
Many COVID-19 antibody tests are not valid for testing vaccine effectiveness due to targeting the wrong proteins or suffering from poor sensitivity and specificity. KSL’s COVID-19 antibody test provides a peace of mind, detecting an immune response in both vaccinated and previously COVID-19 infected individuals.
What are COVID-19 antibodies?
-
Antibodies are one way an individual’s immune system fights infections. People with a healthy immune system develop antibodies against COVID-19 virus shortly after infection. These antibodies are detectable by laboratory tests after about one week after initial infection. In most people, the antibodies clear the COVID-19 infection after about two weeks. While the antibodies are detectable later than the virus, they may help establish the initial diagnosis of a symptomatic patient and offer additional benefits such as indicating an individual’s resistance to the virus and reinfection — if the virus is no longer detectable, these people present a minimal risk of spreading the virus.
What can my COVID-19 test results tell me?
- Consult this table for basic interpretation of results. This is a guide. Please consult your healthcare provider assistance with your diagnosis and more detailed information.
How much does the test cost and who pays for it?
-
COVID-19 Antibody Testing is for isotype-specific IgG, IgM and IgA COVID-19 spike protein (chemiluminescence, $150) and nucleocapsid total antibody (ELISA, $50), or both tests ($200). Testing may be covered by private insurance, Medicaid, Medicare and other governmental reimbursers. If you have specific questions, please call KSL at 1-800-960-1080 to speak with a representative.
Does insurance cover this test?
- Insurance will generally cover testing for patients with a prescription from a doctor.
Are these tests approved by FDA?
- The COVID-19 tests currently offered by KSL are approved by FDA through Emergency Use Authorization (EUA).
Was Bürger zu der gegenwärtigen Situation sagen
Es herrscht ein Verteilungskampf um Wohnraum, Jobs sowie Kita und Schulplätze und sogar an den Tafeln!
Parteien und Staat zerstören unsere Wirtschaft und sind inkompetent aktuelle Probleme zu klären (Armee, Gesundheit, Sicherheit, Bildung ...)!
Ich bin mit der gesamten Entwicklung unzufrieden (Gerechtigkeit, Klima, Flüchtlinge, Feinstaub, Rente, Arbeit ...!
Parteien, Politiker und der Staat vertreten nur ihre eigenen Interessen, nicht unsere und ich bin machtlos dagegen!